Neopharm Co Ltd (092730) Jumps 0.72% on Feb 15

February 15, 2018 - By Michael Collier

Shares of Neopharm Co Ltd (KOSDAQ:092730) last traded at 48900, representing a move of 0.72%, or 350 per share, on volume of 60,704 shares. After opening the trading day at 48550, shares of Neopharm Co Ltd traded in a close range. Neopharm Co Ltd currently has a total float of 7.24 million shares and on average sees 76,723 shares exchange hands each day. The stock now has a 52-week low of 22250 and high of 53000.

KOSPI: A Powerful Indicator Of The Asian Economy

South Korea has one of the most progressive, fast-paced economies in Asia. It is an influential global leader that helps drive growth in the Asian economy. Leading abilities of South Korean market help Neopharm Co Ltd to attract more attention to its work. Without it, the region’s capacities are surely minimized.

One of the most important factors backing South Korea’s successful economy is the Korea Exchange (KRX), which boasts with over $1 trillion in total market capitalization. Despite being one of the youngest stock exchanges in Asia, it has already transformed the conduct of trade and commerce in South Korea. It brings foreign investors to Neopharm Co Ltd and other companies.

Stock Market Division of the KRX

Under the Korea Stock Exchange and Futures Exchange Act, the KRX is divided into three: 1) the Stock Market Division; 2) the KOSDAQ Market Division; and 3) the Derivatives Market Division. All publicly traded companies are listed on the Stock Market Division of the KRX.

The Korea Composite Stock Price Index (KOSPI), which was first published in 1983, is one of the main real-time economy indicators in South Korea as it tracks the performances of all the companies listed on the Stock Market Division of the KRX. That being said, the KOSPI had to be divided into several sub-indices. These include the KOSPI 50, which monitors the 50 most active stocks on the Stock Market Division of the KRX; the KOSPI 100, which monitors the 100 most active stocks; and the KOSPI 200, which monitors the 200 most active stocks out of more than 700 stocks. A stock can be included in the KOSPI 50 and the KOSPI 100 only if it is included in the KOSPI 200. At the same time, a stock can only be included in the KOSPI 50 if it is included in the KOSPI 100. Neopharm Co Ltd is inside the KOSPI trading operations.

The KOSPI tracks stocks on the Stock Market Division of the KRX based on market capitalization using the base value of 100. The base date is January 4, 1980. Similarly, the KOSPI 200, which represents roughly 70% of the total market valuation on the Stock Market Division of the KRX, monitors its components using the base value of 100. The base date is April 2007.

Historical Statistics

In January 1981, the KOSPI had reached its all-time low of 93.10 points. In May 2011, it had reached its all-time high of 2,228.98 points. On the other hand, in June 1998, the KOSPI 200 had reached its all-time low of 31.96 points; and in April 2007, it had reached its all-time high of 100 points.

When the Asian economy was recovering from the financial crisis that had started in Thailand, the KOSPI had recorded its largest one-day gain of 8.50% in June 1998. Meanwhile, after the 9/11 tragedy that had shaken the global economy, the KOSPI had recorded its largest one-day decline of 12.02% in September 2001.

By 2019, Asia is highly expected to account for 26% of the global financial wealth, demonstrating a 2% representation growth in just five years. The best way to bank on that fast-paced growth is to invest on stocks listed on the Stock Market Division of the KRX. Investors which work with Neopharm Co Ltd hope to find the best quality there.

More notable recent Neopharm Co Ltd (KOSDAQ:092730) news were published by: Prnewswire.com which released: “Hope Biosciences Acquires Worldwide Rights To Novel MERTK/AXL Inhibitor From …” on February 01, 2017, also Prnewswire.com with their article: “Pipeline of Asthma Market Covering 129 Companies Reviewed for H1 2016 in New …” published on May 31, 2016, Theguardian.com published: “Fraud case collapse frees co-founders of Goldshield to launch rival bids for it” on May 31, 2015. More interesting news about Neopharm Co Ltd (KOSDAQ:092730) were released by: Globes.Co.Il and their article: “Shlomo Nehama misses out at Jerusalem Economy” published on March 01, 2016 as well as Reuters.com‘s news article titled: “BUZZ-US Stocks on the Move-Euro Tech, Extreme Networks, Hasbro” with publication date: July 21, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: